Dosch Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1995.
1995 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Dosch Pharmaceuticals Private Limited

Dosch Pharmaceuticals Private Limited, a active private limited company, was established on 07 April 1995 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74110MH1995PTC087284. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹45.65 Cr and a paid-up capital of ₹45.64 Cr.

Formerly known as Dosch Pharmatech Private Limited, Non Destructive Engineering Company Private Limited. It upholds a compliant status. Its leadership includes Ashay Sanjay Doshi (Director), Sanjay Kanaiyalal Doshi (Director), Prachi Sanjay Doshi (Director). Past directors included Ashay Sanjay Doshi, Ramesh Bhogilal Parikh, Sanjay Kanaiyalal Doshi. It holds ₹32.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 15 C Laxmi Indl Estate New Link Road Andheri West, Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74110MH1995PTC087284

  • Registration Number

    087284

  • Incorporation Date

    07 April 1995

  • Authorized Capital

    ₹45.65 Cr

  • Paid-Up Capital

    ₹45.64 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 45.65 Cr
  • Paid Up Capital ₹ 45.64 Cr
  • Company Age 30 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 32.65 Cr
  • Revenue Growth **** 30.16%
  • Profit Growth **** -54.01%
  • Ebitda **** 4.87%
  • Net Worth 8.88%
  • Total Assets **** 13.71%
Company report

Dosch Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dosch Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dosch Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ashay Sanjay Doshi Director 15 Oct 2017 Current
Sanjay Kanaiyalal Doshi Director 15 Oct 2017 Current
Prachi Sanjay Doshi Director 15 Mar 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Director 15 Nov 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 15 Mar 2021 Past
Pramod Abcsdd Director 15 Nov 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dosch Pharmaceuticals.

Dosch Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.16% increase. The company also saw a substantial fall in profitability, with a 54.01% decrease in profit. The company's net worth moved up by a moderate rise of 8.88%.

Dosch Pharmaceuticals revenue growth over time
Dosch Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 30.16%
*******
*******
*******
*******
Revenue from Operations
*******
 44.26%
*******
*******
*******
*******
Total Assets
*******
 13.71%
*******
*******
*******
*******
Profit or Loss
*******
 -54.01%
*******
*******
*******
*******
Net Worth
*******
 8.88%
*******
*******
*******
*******
EBITDA
*******
 4.87%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dosch Pharmaceuticals?

In 2023, Dosch Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹326,499,999.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 32.65 Cr
Latest Charge Details
Date Lender Amount Status
07 Jul 2023 Others ₹3.35 Cr Open
26 May 2023 Others ₹2.30 Cr Open
24 Nov 2015 Others ₹27.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Dosch Pharmaceuticals?

Unlock and access historical data on people associated with Dosch Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dosch Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dosch Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dosch Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Dosch Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Dosch Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 2.30 Cr registered on 26 May 2023 with Charge ID 100741025 was modified on 25 Oct 2023. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 3.35 Cr with Charge ID 100743543 was registered on 07 Jul 2023. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 2.30 Cr with Charge ID 100741025 was registered on 26 May 2023. was completed.

  • Director Appointment

    Hemal Bipin Parekh was appointed as a Company Secretary was appointed as a Company Secretary on 01 Dec 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dosch Pharmaceuticals Private Limited?

The CIN of Dosch Pharmaceuticals Private Limited is U74110MH1995PTC087284.

Where is Dosch Pharmaceuticals Private Limited headquartered?

Dosch Pharmaceuticals Private Limited is headquartered at 15 C Laxmi Indl Estate New Link Road Andheri West, Mumbai, Maharashtra, 400053.

When was Dosch Pharmaceuticals Private Limited incorporated?

Dosch Pharmaceuticals Private Limited was incorporated on 07 April 1995.

Who are the current directors of Dosch Pharmaceuticals Private Limited?

The current directors of Dosch Pharmaceuticals Private Limited are

What is the primary industry of Dosch Pharmaceuticals Private Limited?

The primary industry of Dosch Pharmaceuticals Private Limited is Manufacturing.

Is Dosch Pharmaceuticals Private Limited a listed company?

Dosch Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Dosch Pharmaceuticals Private Limited?

The authorized capital of Dosch Pharmaceuticals Private Limited is ₹45.65 Cr, and the paid-up capital is ₹45.64 Cr.

What is the compliance status of Dosch Pharmaceuticals Private Limited?

The compliance status of Dosch Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available